Literature DB >> 28276076

Managing the oral side-effects of medications used to treat multiple sclerosis.

N Cockburn1, K Pateman1, M W Taing2, A Pradhan1, P J Ford1.   

Abstract

BACKGROUND: Many medications used to manage multiple sclerosis (MS) affect oral health. This review aimed to identify the oral side-effects of the current drugs recommended in Australia to treat MS and make dental practitioners aware of the range of symptoms.
METHODS: The Australian Therapeutic Guidelines and the Australian Medicines Handbook were searched for medications used to treat MS. For each medication, the generic name, class, route of administration, dosage and drug company reported side-effects were extracted from the online Monthly Index of Medical Specialties (MIMs) database. Meyler's Side-effect of Drugs Encyclopaedia was used to identify any additional oral adverse reactions to medications used to treat MS.
RESULTS: Fourteen drugs were identified for the treatment of MS progression and 13 drugs for the treatment of MS symptoms. For these medications, 18 oral side-effects were documented: xerostomia was the most common, followed by dysgeusia, dysphagia, mouth ulceration and sinusitis. Anticholinergic drugs caused xerostomia while immunosuppressants resulted in more infection-related side-effects.
CONCLUSIONS: Dental practitioners should be aware of the range of symptoms likely to be reported by this population. Clinicians are encouraged to continue providing dental care for their patients who develop MS and refer complex cases to specialists.
© 2017 Australian Dental Association.

Entities:  

Keywords:  Drugs; management; medication; multiple sclerosis; oral side-effects

Mesh:

Substances:

Year:  2017        PMID: 28276076     DOI: 10.1111/adj.12510

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  5 in total

1.  Cognitive function and oral health in relapsing-remitting multiple sclerosis.

Authors:  Nithin Manchery; Julie D Henry; Andrew Swayne; Reuben Beer; Stefan Blum; Matthew R Nangle
Journal:  Clin Oral Investig       Date:  2021-11-13       Impact factor: 3.573

2.  Accuracy of a questionnaire on xerostomia as a screening tool for hyposalivation.

Authors:  Handerson Nunes de Carvalho; Yuri Lins Dos Santos; Ítalo de Macedo Bernardino; Kênio Costa de Lima; Ana Flávia Granville-Garcia; Edja Maria Melo de Brito Costa
Journal:  Int Dent J       Date:  2020-08-23       Impact factor: 2.607

Review 3.  Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Authors:  Aikaterini Christogianni; Richard Bibb; Scott L Davis; Ollie Jay; Michael Barnett; Nikos Evangelou; Davide Filingeri
Journal:  Temperature (Austin)       Date:  2018-09-05

4.  Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations-Case Report.

Authors:  Céu Costa; Hugo Santiago; Sofia Pereira; Ana Rita Castro; Sandra Clara Soares
Journal:  Diseases       Date:  2022-09-09

Review 5.  Interventions for Nursing Home Residents with Dysphagia-A Scoping Review.

Authors:  Dorte Melgaard; Albert Westergren; Conni Skrubbeltrang; David Smithard
Journal:  Geriatrics (Basel)       Date:  2021-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.